ANTAGONISTES DE LA PROGESTERONE COMME LE CDB-4124 DANS LE TRAITEMENT DE L'ENDOMETRIOSE, DES FIBROMES UTERINS, DE LA DYSMENORRHEE, DU CANCER DU SEIN, ETC.
The present invention relates to methods of administering compositionscomprising a progesterone receptorantagonist for use in treating estrogen-dependent conditions. The invention isalso directed to methods for treating pain associated withendometriosis. The compositions may be administered to females withendometriosis as well as to females undergoing estrogenand/or selective estrogen receptor modulator (SERM) therapy. In certainembodiments, the invention provides a method forsuppressing endometrial proliferation.